Investor Relations
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

SEC Filing Details

Document Details

Filing Date
Feb 24, 2009
Document Date
Feb 13, 2009
Form Description
A preliminary proxy statement containing all other information
Filing Group
Proxy Filings
Company
OPKO Health, Inc.